-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Avidity Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
- Avidity Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$82.6M, a 57% decline year-over-year.
- Avidity Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$285M, a 36.9% decline year-over-year.
- Avidity Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$236M, a 31.7% decline from 2022.
- Avidity Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 51.6% decline from 2021.
- Avidity Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$118M, a 167% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)